Very Early Treatment With Infliximab in Addition to Methotrexate in Early, Poor-Prognosis Rheumatoid Arthritis Reduces Magnetic Resonance Imaging Evidence of Synovitis and Damage, With Sustained Benefit After Infliximab Withdrawal Results From a Twelve-Month Randomized, Double-Blind, Placebo-Controlled Trial
収録刊行物
-
- Arthritis & Rheum
-
Arthritis & Rheum 52 27-, 2005